To use all functions of this page, please activate cookies in your browser.
With an accout for my.bionity.com you can always see everything at a glance – and you can configure your own website and individual newsletter.
- My watch list
- My saved searches
- My saved topics
- My newsletter
Avacta expands following Aptuscan acquisition
12-07-2012: Avacta Group has expanded its Yorkshire headquarters with the addition of new laboratory, office and manufacturing space. The move, which follows the recent acquisition of affinity reagents specialist Aptuscan, brings together the entire Avacta Group on the same site.
The new facilities, which include purpose built laboratories, are at Avacta’s existing Thorp Arch Estate premises in Wetherby, UK, and have been taken on to accommodate the Company’s current rapid expansion.
Contact / Request information
Request further information free of charge:
This is where you can add this news to your personal favourites
- 1Rosetta Resolver® Gene Expression Data Analysis System licensed by Aventis Pharmaceuticals, Inc.
- 2Pharma’s New Hero: Supergenerics Save Money and Improve Drugs
- 3Pro Bono Bio Launches Flexiseq: A Novel Approach to the Treatment of Osteoarthritis
- 4Researchers divide enzyme to conquer genetic puzzle
- 5Merck & Co., Inc. Opens Asia Pacific Regional Headquarters in Singapore
- 6Pharmexa enters into an agreement regarding GV1001 with the Korean company KAEL Co. Ltd
- 7Pharmexa A/S sells Pharmexa-Epimmune to the Korean company VaxOnco, Inc.
- 8Sanofi-aventis to acquire Oenobiol
- 9MIV-210 - a potential drug against hepatitis B and HIV - enters phase II
- 10Vivacta Initiates Development of Point of Care Test for Vitamin D
- Resolutions of the Annual General Meeting of Evotec
- ZEISS to acquire Xradia to complement its microscopy business
- DHL launches industry-changing temperature controlled Life Sciences air frei ...
- Novasep appoints Udo Steinhauer as fine chemicals market director
- Merck’s credit rating raised by Standard & Poor’s to ‘A’
- PRAC recommends restricting the use of codeine when used for pain relief in children
- PRAC recommends the same cardiovascular precautions for diclofenac as for selective COX-2 inhibitors
- Frost & Sullivan anticipates large-scale switch to digital pathology systems
- European Medicines Agency and EUnetHTA review progress of their cooperation
- Non-invasive first trimester blood test reliably detects Down's syndrome